Kurt Schalper | Director, Translational Immuno Oncology Laboratory
Yale Cancer Center

Appearances:

Day One @ 15:40

Combination precision therapies in oncology

•     Combining molecular and biological technology to identify patient cohorts
•     Personalized protection against cancer relapse and metastases
•     Understanding how to target resistance mechanisms